Committee Composition

Below is a summary of our committee structure and membership information. To read more about any of the committees, click on committee names in the chart below.
Chairperson Chairperson Committee Member Member Financial Expert Financial Expert
 Audit CommitteeNominating and Governance CommitteeCompensation CommitteeScience & Technology Committee
Sunil Agarwal, M.D. 
Sunil Agarwal, M.D.
Independent Director


Sunil Agarwal, M.D., joined our board of directors in March 2016. Dr. Agarwal serves as executive vice president and chief medical officer for Ultragenyx Pharmaceutical, where he leads the company's clinical development and operations, regulatory affairs, biometrics, pharmacovigilance, medical affairs, pharmacology and toxicology. Dr. Agarwal served in various leadership roles at Genentech for more than a decade, including senior vice president and global head of clinical development for opht... 

Committee Member   Committee Member Committee Member
Mary Cranston Financial Expert
Mary Cranston
Independent Director


Mary Cranston joined MyoKardia as an independent director in April 2016. Ms. Cranston is a retired senior partner of Pillsbury Winthrop Pittman LLP, an international law firm. She was formerly chair and chief executive officer of Pillsbury.

Ms. Cranston currently serves as a director of Visa Inc., The Chemours Company and CSAA Insurance. She is also the chair of the board of the Stanford Children's Hospital and Children's Health Network. She previously served as a member of the boards... 

Chairperson    
Tassos Gianakakos 
Tassos Gianakakos
Chief Executive Officer


Tassos Gianakakos joined MyoKardia in October 2013, bringing more than 17 years of senior leadership experience and business development and finance expertise in the biopharmaceutical industry to the company. He joined MyoKardia from MAP Pharmaceuticals (acquired by Allergan in March 2013), where he was most recently senior vice president and chief business officer. In this position, Mr. Gianakakos played an integral role in advancing the company’s two Phase 3 clinical programs and regulatory... 

    
Charles Homcy, M.D. 
Charles Homcy, M.D.
Venture Parter


Charles Homcy, M.D., has significant experience building and leading successful biotech companies. Dr. Homcy joined Third Rock Ventures in 2010 as a venture partner. Previously, he served as president and chief executive officer of Portola Pharmaceuticals since co-founding the company in 2003 until 2010. Prior to that, Dr. Homcy was the president of research and development at Millennium following the company's acquisition of COR Therapeutics in 2002. He joined COR in 1995 as executive vice p... 

    Committee Member
Mark Perry Financial Expert
Mark Perry
Independent Director


Mark Perry is a biotech veteran with more than 30 years of industry experience. Mr. Perry has served as an entrepreneur-in-residence at Third Rock Ventures and as president, chief executive officer and director of Aerovance, Inc., a biotechnology company focused on the development of human therapeutics for respiratory and allergic diseases. From 1994 to 2007, Mr. Perry served in several executive roles at Gilead Sciences, Inc., including executive vice president of operations, as well as gene... 

Committee Member Chairperson Chairperson  
Kevin Starr Financial Expert
Kevin Starr
Co-Founder and Partner


Kevin Starr is a proven operational leader with more than 25 years of experience building and operating leading biotech companies. Mr. Starr co-founded Third Rock Ventures in 2007 and focuses on the formation, development and business strategy of the firm's portfolio companies as well as actively identifying and evaluating new investments. In addition to his role at Third Rock, he also serves as the interim chief executive officer of SAGE Therapeutics. Prior to Third Rock Ventures, Mr. Starr ... 

    
Eric J. Topol, M.D. 
Eric J. Topol, M.D.
Independent Director


Eric J. Topol, M.D., joined MyoKardia in September 2015 as a member of our board of directors and as chair of our Science and Technology Committee. Since 2006, Dr. Topol has served as a Professor of Translational Genomics at the Scripps Research Institute, the Director of the Scripps Translational Science Institute, a Senior Consultant in the Division of Cardiovascular Diseases at Scripps Clinic and the Chief Academic Officer for Scripps Health, where in 2009 he was named the Gary and Mary We... 

  Committee Member Committee Member Chairperson